Board-linked hedge funds have filed a wave of sell transactions this week. The largest cluster hit CVS Health, where Lawrence Robbins — a hedge fund manager sitting on the board — filed sales totalling over $315M across multiple trades between May 19 and 21. CVS's own CTO, Tilak Mandadi, also filed a $6.2M sale earlier this month. The combined selling pressure is hard to ignore.
At Twilio, board member Andy Stafman filed two large block sales in May. The first, worth $130.6M on May 12, was followed by a second $184M sale filed May 27. That's nearly $315M in total — all at prices between $184 and $193 per share. Twilio shares have rallied sharply in 2026, which may explain the rush to lock in gains.
On the buying side, Capital Group quietly accumulated $285M worth of BeOne Medicines shares around May 20. The institutional 5% owner added 943,000 shares at roughly $302 each. That's a strong vote of confidence in the oncology biotech.
Meanwhile, Solaris Energy Infrastructure saw its Chief Legal Officer file two sales totalling nearly $2.6M in mid-May. A separate 10% owner also sold $141.5M worth of stock in late April, filed May 4.
The contrast is clear. Buyers are building positions in healthcare innovation. Sellers are cashing out of recovery plays. This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
